Symbol: |
SACS
|
Description: |
spastic ataxia of Charlevoix-Saguenay (sacsin) [Source:HGNC Symbol;Acc:10519]
|
Location: |
Chr13:23902965-24007841[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:223
Gene |
Compound |
Gen_sig |
Exp_pattern |
SACS |
NSC 658089 |
0.012 |
Down |
SACS |
2-(2-(Dimethylamino)ethylamino)naphthazarin |
0.011 |
Up |
SACS |
NSC 658288 |
0.009 |
Down |
SACS |
1,3-dimethyl-2,4-dioxo(1H,3H)pyrimido dimethyltetrathiafulvalene |
0.017 |
Down |
SACS |
Fluorene, 9-bromo-2,4,7-trichloro- |
0.04 |
Down |
SACS |
Nitrotolazoline |
0.039 |
Down |
SACS |
Azoxydapsone {1,2-bis-[4-(4'-aminophenylsulfonylphenyl)]- diazine-1-oxide} |
0.006 |
Down |
SACS |
NSC 667873 |
0.006 |
Down |
SACS |
NSC 667874 |
0.027 |
Up |
SACS |
NSC 669308 |
0.006 |
Down |
SACS |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.039 |
Up |
SACS |
NSC 670877 |
0.037 |
Up |
SACS |
NSC 671002 |
0.028 |
Down |
SACS |
Benzoic acid, 2,4-dichloro-, 6-acetyl-1,2,3,4-tetrahydro- 4-oxo-1,3-diphenyl-2-thioxothieno[2,3-d]pyrimidin-5-yl ester |
0.024 |
Down |
SACS |
Hexadecylphospho(N-acetyl)-L-serine (NH4 salt) |
0.019 |
Down |
Expression pattern: Sensitivity / Resistance
Total:15 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:53
Total:4 Current:1
[First] [Prev]  Next Last 
|